Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
Previous studies suggest that protective immunity against Schistosoma haematobium is primarily stimulated by antigens from dying worms. Praziquantel treatment kills adult worms, boosting antigen exposure and protective antibody levels. Current schistosomiasis control efforts use repeated mass drug a...
Saved in:
Main Authors: | Kate M Mitchell (Author), Francisca Mutapi (Author), Takafira Mduluza (Author), Nicholas Midzi (Author), Nicholas J Savill (Author), Mark E J Woolhouse (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011) -
Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children.
by: Laura J Appleby, et al.
Published: (2012) -
Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children.
by: Gemma Louise Kay, et al.
Published: (2015) -
Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children.
by: Derick N M Osakunor, et al.
Published: (2020) -
Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infection.
by: Norman Nausch, et al.
Published: (2012)